Jens is a member of the Advisory Board at apollo.vc
He has more than 18 years of biopharma venture capital and company creation experience and 10 years of operational experience in drug discovery and development.
Jens previously served as President of GlaxoSmithKline’s corporate venture fund SR One where during his tenure the SR One team invested over 500 million USD and was involved in 18 IPOs such as CRISPR Therapeutics, TP Therapeutics and Principia, as well as 12 M&A transactions.
Jens is a Kauffman Fellow, a member of the EU-sponsored Gold Track Expert Council, and a passionate mentor for entrepreneurs and start-up teams in the area of innovative life science and healthcare IT.
Jens is a member of the Advisory Board at apollo.vc
He has more than 18 years of biopharma venture capital and company creation experience and 10 years of operational experience in drug discovery and development.
Jens previously served as President of GlaxoSmithKline’s corporate venture fund SR One where during his tenure the SR One team invested over 500 million USD and was involved in 18 IPOs such as CRISPR Therapeutics, TP Therapeutics and Principia, as well as 12 M&A transactions.
Jens is a Kauffman Fellow, a member of the EU-sponsored Gold Track Expert Council, and a passionate mentor for entrepreneurs and start-up teams in the area of innovative life science and healthcare IT.
